Stocksigma LogoStocksigma Logo

Aurobindo Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 1,02,633 (+23.9% YoY | +12.2% QoQ) ■ EBITDA: 21,558 (+28.5% YoY | +14.6% QoQ) ■ EBITDA Margin (%): 21.0 (+75 bps YoY | +45 bps QoQ) ■ PAT

Aurobindo Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Aurobindo Pharma Ltd · Outcome · 05 Nov 2026, 1:23 am

Aurobindo Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 1,02,633 (+23.9% YoY | +12.2% QoQ) ■ EBITDA: 21,558 (+28.5% YoY | +14.6% QoQ) ■ EBITDA Margin (%): 21.0 (+75 bps YoY | +45 bps QoQ) ■ PAT: 11,261 (+32.7% YoY | +9.1% QoQ) ■ EPS (INR): 19.6 (+33.9% YoY | +9.6% QoQ)

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements